Pros and Cons of The Gene Therapy

When Avery's pneumococcal transformation experiment (OT Avery 1877-1955) was first discovered in 1904, DNA was a transmitter of genetic information. (Baruch S, Huang S, Prichard D, et al., 2005) A number of academic subjects related to genes have emerged. Through them, gene therapy closely related to human life is the most controversial topic. Gene therapy gives us hope for many diseases that we believe are hard to heal before but the disadvantages of genes are death by gene therapy, evolutionary problems due to DNA exchange, review and treatment of gene experiments It is an ethical flaw such as.

The pros and cons of gene therapy tells us that with the progress of this technology there are some annoying questions to answer. The hope that it provides is extraordinary. Since we are working to treat some of the most devastating diseases humans are currently experiencing, there may be unexpected side effects that may cause harm than good.

Our view on gene therapy is somewhat positive, but on the other hand it is a little. First, we do not believe that gene therapy should be used in situations where traditional methods can help disease. We believe that gene therapy should be the last resort, and the doctor will use it when all other methods fail. Instead, gene therapy should be used to help individuals with fatal diseases. CF is one example. Gene therapy may be their only answer if it can prolong the lifespan of a person or otherwise improve the lives of those without opportunities. We believe that everything is natural and natural. If gene therapy is useful for the survival of individuals, please use it. Otherwise, please leave enough space

Current gene therapy research focuses on treating individuals by targeting somatic cells such as bone marrow or blood cells. This gene therapy is not handed down to a human child. However, gene therapy can target eggs and sperm cells (reproductive cells), which makes it possible to transfer the inserted genes to future generations. This method is called germline gene therapy. The idea of ​​germline gene therapy is controversial. It can protect future generations of families from specific genetic diseases, but it may have unexpected long term side effects, which may affect fetal development in unexpected ways. People affected by germline gene therapy have not yet been born, so we can not choose whether to receive treatment. Because of these ethical concerns, the US government has not granted federal funds for research on human germline gene therapy.